本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Oric Pharmaceuticals Inc.

12.05
+0.01000.08%
成交量:9.59萬
成交額:114.65萬
市值:12.47億
市盈率:-8.92
高:12.15
開:12.08
低:11.86
收:12.04
52周最高:14.93
52周最低:7.23
股本:1.04億
流通股本:8,868.67萬
量比:2.34
換手率:0.11%
股息:- -
股息率:- -
每股收益(TTM):-1.3513
每股收益(LYR):-1.4747
淨資產收益率:-39.80%
總資產收益率:-25.97%
市淨率:3.27
市盈率(LYR):-8.17

資料載入中...

2024/03/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/29

重要事件披露

Form 8-K - Current report
2024/03/11

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/11

重要事件披露

Form 8-K - Current report
2024/03/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/01

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/01

SEC問詢函

Form CORRESP - Correspondence
2024/01/30

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/26

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/22

重要事件披露

Form 8-K - Current report
2024/01/09

重要事件披露

Form 8-K - Current report
2023/12/27

SEC問詢函

Form CORRESP - Correspondence
2023/12/12

重要事件披露

Form 8-K - Current report
2023/11/06

重要事件披露

Form 8-K - Current report
2023/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]